Engineering - Industrial Equipments · Founded 1962 · www.gmmpfaudler.com · BSE 505255 · NSE GMMPFAUDLR · ISIN INE541A01023
No Notes Added Yet
Business
GMM Pfaudler Ltd. is a global provider of highly engineered process equipment and systems, primarily for the chemical, specialty chemical, pharmaceutical, and other process industries. The company's core business revolves around corrosion-resistant technologies, particularly glass-lined equipment (reactors, storage tanks), along with a diversified portfolio that includes filtration, drying, mixing, sealing, and thermal products. GMM Pfaudler designs, manufactures, and services this critical equipment, enabling clients to handle corrosive, hazardous, or high-purity materials safely and efficiently. It makes money by selling new equipment, providing aftermarket services (spare parts, repairs, upgrades), and offering engineering solutions.
Revenue Mix
While specific granular revenue mix fluctuates, the company's business can be broadly categorized into:
Glass-Lined Equipment: This remains a foundational segment, offering reactors, storage tanks, and accessories crucial for corrosion resistance in chemical and pharmaceutical processes.
Other Process Technologies: This includes a range of products like filtration and drying equipment, mixing solutions, thermal systems (heat exchangers), and sealing technologies. This segment has grown significantly through strategic acquisitions, diversifying the product portfolio beyond traditional glass-lining.
Aftermarket Services: A recurring revenue stream comprising spare parts, maintenance, upgrades, and technical support for its installed base globally.
Industry
GMM Pfaudler operates within the specialized industrial equipment manufacturing sector, serving niche markets within chemicals, pharmaceuticals, and allied process industries. The industry is characterized by high technical requirements, stringent quality standards, and a need for reliable, long-lifecycle equipment. GMM Pfaudler is a global leader, particularly in glass-lined process equipment, having acquired the global Pfaudler business. It holds a strong competitive position globally and is a dominant player in India, competing with a few other global specialized manufacturers and regional players. Its positioning is built on deep technical expertise, a wide product range, and a global manufacturing and service footprint.
MOAT
Technology & Expertise: Manufacturing glass-lined equipment involves complex proprietary processes and significant know-how (fusing glass to steel), creating high barriers to entry.
Brand & Reputation: Pfaudler is a globally recognized and trusted brand, especially in critical applications within the pharmaceutical and specialty chemical industries where quality, reliability, and safety are paramount.
High Switching Costs: Once a specific type of equipment from a trusted supplier like Pfaudler is integrated into a chemical or pharmaceutical process plant, switching to an alternative supplier can involve significant re-engineering, re-validation, and operational risks.
Global Footprint & Service Network: A widespread manufacturing and service network enables global reach, localized support, and quicker response times for complex projects and aftermarket needs.
Growth Drivers
Global CAPEX Cycles: Capital expenditure by chemical, specialty chemical, and pharmaceutical industries, driven by new product development, capacity expansion, and modernization.
Pharmaceutical & Biopharma Growth: Continued R&D and manufacturing investments in generic and patented drugs, particularly in emerging markets and biopharma.
Specialty Chemicals Expansion: Growing demand for specialty chemicals across various end-user industries globally.
Aftermarket Revenue: An expanding global installed base drives recurring demand for spare parts, service, and upgrades.
Product Diversification & Cross-selling: Leveraging the expanded global portfolio (post-acquisitions) to cross-sell diverse process technologies to existing and new customers.
Risks
Cyclicality: Demand for industrial equipment is linked to global and regional industrial CAPEX cycles, making it susceptible to economic downturns.
Raw Material Price Volatility: Fluctuations in prices of key inputs like steel, glass, and other components can impact profitability.
Global Economic Slowdown: A prolonged slowdown can lead to deferred investment decisions by customers, impacting new order intake.
Currency Fluctuations: As a global entity with significant international revenues and costs, adverse movements in foreign exchange rates can impact financial performance.
Competition: Intense competition from other global and regional players in various product segments.
Integration Risks: Challenges in fully integrating past and future acquisitions, realizing synergies, and managing a diversified global organization.
Management & Ownership
GMM Pfaudler is significantly owned and promoted by the global Pfaudler Group (ultimately controlled by private equity firm Deutsche Beteiligungs AG - DBAG and its co-investors) since its acquisition of the global Pfaudler business. This structure provides access to global expertise and resources. The management team comprises experienced professionals with a track record in the industrial equipment sector and in integrating global operations. The ownership structure features a dominant promoter group alongside institutional and public shareholders.
Outlook
GMM Pfaudler benefits from its strong global brand, diversified product portfolio, and leadership position in highly specialized niches like glass-lined equipment. The company is well-positioned to capitalize on ongoing capital expenditure cycles in the global pharmaceutical, specialty chemical, and other process industries. Its robust aftermarket business provides a degree of revenue stability. However, the outlook is also subject to potential headwinds such as global economic slowdowns impacting industrial CAPEX, raw material price volatility, and the challenges inherent in managing and integrating a complex global manufacturing and service operation. Future growth will largely depend on the sustained health of its core end-markets, successful execution of its global strategy, and its ability to leverage cross-selling opportunities across its expanded product and geographical footprint.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 741 | 785 | 805 | 801 | 807 | 795 | 902 | 884 | 944 | 925 |
| Other Income | 11 | 10 | -1 | 26 | -5 | 9 | 9 | 9 | 18 | 10 |
| Total Income | 751 | 795 | 805 | 827 | 802 | 804 | 911 | 892 | 962 | 935 |
| Total Expenditure | 651 | 697 | 712 | 706 | 723 | 694 | 781 | 779 | 868 | 831 |
| Operating Profit | 100 | 99 | 93 | 122 | 79 | 110 | 130 | 114 | 93 | 104 |
| Interest | 30 | 25 | 26 | 25 | 27 | 43 | 30 | 34 | 16 | 23 |
| Depreciation | 39 | 35 | 36 | 35 | 38 | 36 | 36 | 37 | 42 | 41 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -48 | 0 | 0 | -56 | -9 | 0 |
| Profit Before Tax | 31 | 38 | 30 | 62 | -34 | 32 | 64 | -14 | 26 | 40 |
| Provision for Tax | 6 | 17 | 15 | 22 | -6 | 21 | 25 | -5 | 11 | 18 |
| Profit After Tax | 25 | 22 | 15 | 40 | -28 | 10 | 39 | -9 | 15 | 22 |
| Adjustments | 2 | 1 | -0 | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
| Profit After Adjustments | 28 | 23 | 15 | 41 | -27 | 11 | 41 | -8 | 17 | 24 |
| Adjusted Earnings Per Share | 6.1 | 5.2 | 3.4 | 9.2 | -6 | 2.5 | 9.2 | -1.8 | 3.8 | 5.3 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 292 | 353 | 406 | 503 | 591 | 1001 | 2541 | 3178 | 3446 | 3199 | 3524 | 3655 |
| Other Income | 4 | 6 | 9 | 9 | 6 | 23 | 7 | 52 | 23 | 30 | 50 | 46 |
| Total Income | 296 | 359 | 415 | 511 | 597 | 1025 | 2548 | 3229 | 3470 | 3229 | 3573 | 3700 |
| Total Expenditure | 257 | 306 | 344 | 426 | 480 | 862 | 2257 | 2748 | 2974 | 2838 | 3126 | 3259 |
| Operating Profit | 39 | 53 | 71 | 85 | 117 | 162 | 291 | 481 | 496 | 392 | 448 | 441 |
| Interest | 1 | 1 | 1 | 1 | 3 | 10 | 25 | 67 | 95 | 103 | 123 | 103 |
| Depreciation | 8 | 8 | 10 | 11 | 21 | 50 | 133 | 122 | 150 | 144 | 158 | 156 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -34 | 0 | -22 | 0 | -48 | -65 | -65 |
| Profit Before Tax | 30 | 44 | 61 | 73 | 92 | 68 | 133 | 271 | 251 | 96 | 102 | 116 |
| Provision for Tax | 10 | 13 | 18 | 23 | 21 | 5 | 58 | 61 | 80 | 47 | 50 | 49 |
| Profit After Tax | 20 | 31 | 43 | 51 | 71 | 64 | 75 | 210 | 171 | 49 | 52 | 67 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 10 | 10 | -47 | 5 | 4 | 6 | 7 |
| Profit After Adjustments | 20 | 31 | 43 | 51 | 71 | 73 | 85 | 164 | 175 | 53 | 58 | 74 |
| Adjusted Earnings Per Share | 4.6 | 7.2 | 9.7 | 11.5 | 16.2 | 16.8 | 19.4 | 36.4 | 39 | 11.8 | 12.9 | 16.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 10% | 4% | 29% | 28% |
| Operating Profit CAGR | 14% | -2% | 23% | 28% |
| PAT CAGR | 6% | -37% | -4% | 10% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 12% | -10% | -5% | 25% |
| ROE Average | 5% | 10% | 15% | 17% |
| ROCE Average | 12% | 15% | 17% | 21% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 167 | 194 | 228 | 269 | 329 | 406 | 527 | 801 | 964 | 1023 | 1205 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 116 | 141 | 11 | 6 | 7 | 28 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 443 | 450 | 641 | 501 | 434 | 545 |
| Other Non-Current Liabilities | 4 | 11 | 17 | 20 | 90 | 603 | 649 | 512 | 548 | 496 | 697 |
| Total Current Liabilities | 84 | 147 | 190 | 176 | 164 | 910 | 1069 | 1524 | 1202 | 1182 | 1570 |
| Total Liabilities | 256 | 351 | 434 | 465 | 583 | 2478 | 2858 | 3488 | 3222 | 3141 | 4045 |
| Fixed Assets | 53 | 61 | 71 | 78 | 134 | 1043 | 1002 | 1224 | 1251 | 1165 | 1497 |
| Other Non-Current Assets | 11 | 4 | 9 | 11 | 60 | 15 | 148 | 60 | 82 | 41 | 68 |
| Total Current Assets | 192 | 286 | 354 | 376 | 390 | 1419 | 1582 | 2205 | 1889 | 1888 | 2480 |
| Total Assets | 256 | 351 | 434 | 465 | 583 | 2478 | 2858 | 3488 | 3222 | 3141 | 4045 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 35 | 36 | 31 | 67 | 75 | 48 | 243 | 308 | 311 | 320 | 445 |
| Cash Flow from Operating Activities | 25 | 22 | 68 | 27 | 27 | 157 | 236 | 185 | 284 | 378 | 389 |
| Cash Flow from Investing Activities | -18 | -21 | -24 | -8 | -50 | -66 | -117 | -311 | -32 | -52 | -154 |
| Cash Flow from Financing Activities | -6 | -6 | -8 | -10 | -5 | 105 | -55 | 130 | -244 | -201 | -44 |
| Net Cash Inflow / Outflow | 1 | -5 | 35 | 9 | -28 | 196 | 65 | 4 | 8 | 125 | 191 |
| Closing Cash & Cash Equivalent | 36 | 31 | 67 | 75 | 48 | 243 | 291 | 311 | 320 | 445 | 635 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.59 | 7.15 | 9.73 | 11.54 | 16.22 | 16.77 | 19.42 | 36.37 | 39.04 | 11.78 | 12.86 |
| CEPS(Rs) | 6.44 | 8.98 | 11.97 | 14.04 | 21.04 | 26.03 | 47.48 | 73.9 | 71.4 | 43.07 | 46.59 |
| DPS(Rs) | 3 | 4 | 4 | 4.5 | 5 | 5 | 6 | 2 | 2 | 2 | 2 |
| Book NAV/Share(Rs) | 38.05 | 44.21 | 51.94 | 61.34 | 75.05 | 92.75 | 120.23 | 177.39 | 213.27 | 226.06 | 267.74 |
| Core EBITDA Margin(%) | 11.3 | 12.56 | 14.86 | 15.19 | 18.76 | 13.72 | 11.12 | 13.47 | 13.71 | 11.29 | 11.3 |
| EBIT Margin(%) | 9.85 | 11.89 | 14.77 | 14.73 | 16.17 | 7.74 | 6.19 | 10.59 | 10.03 | 6.23 | 6.38 |
| Pre Tax Margin(%) | 9.63 | 11.65 | 14.52 | 14.5 | 15.58 | 6.73 | 5.23 | 8.5 | 7.28 | 3.01 | 2.89 |
| PAT Margin (%) | 6.5 | 8.23 | 10.22 | 10.01 | 12.01 | 6.28 | 2.95 | 6.6 | 4.95 | 1.54 | 1.47 |
| Cash Profit Margin (%) | 9.13 | 10.41 | 12.56 | 12.18 | 15.57 | 11.28 | 8.16 | 10.42 | 9.31 | 6.05 | 5.94 |
| ROA(%) | 8.21 | 10.26 | 10.86 | 11.25 | 13.58 | 4.15 | 2.82 | 6.63 | 5.09 | 1.55 | 1.44 |
| ROE(%) | 12.68 | 17.26 | 20.25 | 20.37 | 23.79 | 17.29 | 16.16 | 31.78 | 19.44 | 4.98 | 4.67 |
| ROCE(%) | 19.22 | 24.93 | 29.26 | 29.98 | 31.44 | 12.64 | 16.37 | 25.68 | 21.11 | 11.91 | 12.11 |
| Receivable days | 51.14 | 57.23 | 52.62 | 42.52 | 43.6 | 69.29 | 47.65 | 45.33 | 45.98 | 46.76 | 44.13 |
| Inventory Days | 85.6 | 73.9 | 77.72 | 76.25 | 74.33 | 126.73 | 89.16 | 82.57 | 74.04 | 66.51 | 60.97 |
| Payable days | 100.44 | 104.23 | 125.02 | 97.75 | 91.86 | 149.37 | 124.8 | 131.95 | 123.03 | 111.68 | 110.68 |
| PER(x) | 18.3 | 24.27 | 23.54 | 34.67 | 51.65 | 85.59 | 78.34 | 40.3 | 31.66 | 85.94 | 61.7 |
| Price/Book(x) | 2.21 | 3.93 | 4.41 | 6.52 | 11.17 | 15.47 | 12.65 | 8.26 | 5.79 | 4.48 | 2.96 |
| Dividend Yield(%) | 1.19 | 0.77 | 0.58 | 0.38 | 0.2 | 0.12 | 0.13 | 0.14 | 0.16 | 0.2 | 0.25 |
| EV/Net Sales(x) | 1.08 | 2.07 | 2.31 | 3.34 | 6.11 | 6.48 | 2.69 | 2.21 | 1.72 | 1.48 | 1.05 |
| EV/Core EBITDA(x) | 8.15 | 13.71 | 13.12 | 19.65 | 30.87 | 39.97 | 23.54 | 14.58 | 11.95 | 12.1 | 8.3 |
| Net Sales Growth(%) | -5.06 | 20.87 | 14.92 | 23.9 | 17.59 | 69.37 | 153.77 | 25.07 | 8.46 | -7.19 | 10.17 |
| EBIT Growth(%) | 6.21 | 47.48 | 37.19 | 20.69 | 28.66 | -18.31 | 101.92 | 113.72 | 2.35 | -42.29 | 12.71 |
| PAT Growth(%) | 6.61 | 54.72 | 37.12 | 18.52 | 40.63 | -10.66 | 18.58 | 179.15 | -18.88 | -71.19 | 5.39 |
| EPS Growth(%) | 6.62 | 55.88 | 36.1 | 18.52 | 40.63 | 3.35 | 15.81 | 87.32 | 7.32 | -69.81 | 9.16 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0.03 | 1.21 | 0.96 | 1 | 0.74 | 0.64 | 0.69 |
| Current Ratio(x) | 2.27 | 1.95 | 1.87 | 2.14 | 2.37 | 1.56 | 1.48 | 1.45 | 1.57 | 1.6 | 1.58 |
| Quick Ratio(x) | 1.43 | 1.39 | 1.36 | 1.48 | 1.61 | 0.93 | 0.85 | 0.94 | 1.05 | 1.14 | 1.17 |
| Interest Cover(x) | 44.31 | 49.9 | 59.83 | 63.52 | 27.44 | 7.69 | 6.42 | 5.07 | 3.65 | 1.93 | 1.83 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.08 | 0.12 | 0.13 | 0.14 | 0.23 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 |
| FII | 22.2 | 14.62 | 19.67 | 20.75 | 21.02 | 20.77 | 17.73 | 17.15 | 14.39 | 13.22 |
| DII | 14.52 | 15.8 | 14.44 | 15.42 | 15.74 | 16.2 | 16.29 | 17.58 | 18.42 | 19.14 |
| Public | 38.11 | 44.4 | 40.71 | 38.65 | 38.05 | 37.86 | 40.8 | 40.09 | 42.02 | 42.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
| FII | 1 | 0.66 | 0.88 | 0.93 | 0.95 | 0.93 | 0.8 | 0.77 | 0.65 | 0.59 |
| DII | 0.65 | 0.71 | 0.65 | 0.69 | 0.71 | 0.73 | 0.73 | 0.79 | 0.83 | 0.86 |
| Public | 1.71 | 2 | 1.83 | 1.74 | 1.71 | 1.7 | 1.83 | 1.8 | 1.89 | 1.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +10% | +4% | +29% | +28% |
| Operating Profit CAGR | +14% | -2% | +23% | +28% |
| PAT CAGR | +6% | -37% | -4% | +10% |
| Share Price CAGR | +12% | -10% | -5% | +25% |
| ROE Average | +5% | +10% | +15% | +17% |
| ROCE Average | +12% | +15% | +17% | +21% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 | 25.18 |
| FII | 22.2 | 14.62 | 19.67 | 20.75 | 21.02 | 20.77 | 17.73 | 17.15 | 14.39 | 13.22 |
| DII | 14.52 | 15.8 | 14.44 | 15.42 | 15.74 | 16.2 | 16.29 | 17.58 | 18.42 | 19.14 |
| Public | 38.11 | 44.4 | 40.71 | 38.65 | 38.05 | 37.86 | 40.8 | 40.09 | 42.02 | 42.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
| FII | 1 | 0.66 | 0.88 | 0.93 | 0.95 | 0.93 | 0.8 | 0.77 | 0.65 | 0.59 |
| DII | 0.65 | 0.71 | 0.65 | 0.69 | 0.71 | 0.73 | 0.73 | 0.79 | 0.83 | 0.86 |
| Public | 1.71 | 2 | 1.83 | 1.74 | 1.71 | 1.7 | 1.83 | 1.8 | 1.89 | 1.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.